Concepedia

K.-H. Schlingensiepen

KS

Statistics

Publications

21

Citations

1.3K

H-Index

15

Active since

1984

Affiliations

Max Planck Institute for Biophysical Chemistry(Current)

Max Planck Society

University of Würzburg

All India Institute of Medical Sciences

K.-H. Schlingensiepen is an author at Max Planck Institute for Biophysical Chemistry specializing in oncology, medicine, and cancer immunotherapy.

Publications per year

1984–2011

21

Publications

21

Targeted therapy for high-grade glioma with the TGF- 2 inhibitor trabedersen: results of a randomized and controlled phase IIb study

Ulrich Bogdahn, Peter Hau, Günther Stockhammer et al. · Neuro-Oncology · 2010 · 428 citations · Full text

Medicine, Oncology, Pharmacology +16

Block of c‐Fos and JunB Expression by Antisense Oligonucleotides Inhibits Light‐induced‐Phase Shifts of the Mammalian Circadian Clock

Franziska Wollnik, W. Brysch, Eugen Uhlmann et al. · European Journal of Neuroscience · 1995 · 187 citations · Full text

Life Sciences, Molecular Biology, Neurobiology +17

The effect of transforming growth factor-β2-specific phosphorothioate-anti-sense oligodeoxynucleotides in reversing cellular immunosuppression in malignant glioma

Piotr Jachimczak, Ulrich Bogdahn, Christian Behl et al. · Journal of neurosurgery · 1993 · 148 citations

Medicine, Immunology, Oncology +17

Regional and temporal expression of sodium channel messenger RNAs in the rat brain during development

W. Brysch, O. Creutzfeldt, K. L�no et al. · Experimental Brain Research · 1991 · 82 citations

Life Sciences, Neurobiology, Neuroscience +16

Clearance kinetics, biodistribution, and organ saturability of phosphorothioate oligodeoxynucleotides in mice.

A Rifai, W. Brysch, Kim Fadden et al. · PubMed · 1996 · 66 citations

Pharmacy, Biochemistry, Pharmacokinetics +13

1–5 of 21